ALEUP.PA drops 81.23% to €0.29 on 02 Jan 2026 after hours: key risks ahead

ALEUP.PA drops 81.23% to €0.29 on 02 Jan 2026 after hours: key risks ahead

The ALEUP.PA stock fell sharply in after hours on 02 Jan 2026, trading at €0.29 after a one-day move of -81.23% from the previous close of €1.54. Europlasma S.A. (ALEUP.PA) is listed on EURONEXT and operates in Europe in the Waste Management industry. The move came on heavy relative volume of 377,553 shares versus an average of 152,945. This report uses Meyka AI-powered market analysis platform data to connect recent price action with fundamentals, technicals and model forecasts to help investors assess near-term risk and potential scenarios.

Price action and immediate drivers

Europlasma S.A. (ALEUP.PA) closed after hours at €0.29, down €1.25 or -81.23% on 02 Jan 2026. The stock opened at €0.45, made a day high of €0.45 and a low of €0.22 on volume of 377,553 shares. The move pushed the 50-day average to €0.49 and left the 200-day average at €12.41, signalling extreme divergence from recent trading ranges. High relative volume (2.47x average) suggests a concentrated selling event rather than typical thin-market noise.

Fundamentals and valuation snapshot

At €0.29 the company carries a market cap of €507,053,390.00 with 1,754,510,000 shares outstanding. Europlasma shows negative EPS of -91.38 and no PE multiple. Key ratios: price/sales 11.94, price/book -28.15 and current ratio 0.77, below the Industrials sector average current ratio of 2.75. Free cash flow per share is -0.01 and operating cash flow per share is -0.01. Those metrics point to weak near-term profitability and tight liquidity compared with peers.

Technical outlook and near-term targets

Technically, momentum indicators are negative: RSI 44.96, MACD histogram -0.11 and ROC -83.90%. Bollinger middle band sits at €0.78 while the lower band is negative, reflecting rapid price compression. Immediate support is visible near €0.22 (day low) and resistance near €0.50 (50-day average and intraday high). Short-term price targets: conservative support target €0.15, base case €0.25, and upside recovery test near €1.50 if liquidity and news improve.

Meyka AI grade and model forecast

Meyka AI rates ALEUP.PA with a score of 73.31 out of 100 — Grade B+ (BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly level of €0.23, implying a -20.42% move from the current €0.29. Forecasts are model-based projections and not guarantees. The grade and model flag a mix of strong long-term recovery potential versus very weak near-term cash metrics.

Sector and peer context

Europlasma sits in the Industrials sector, Waste Management industry. Industrials peers show healthier liquidity and higher average ROE (sector avg ROE 10.51) while Europlasma’s return metrics are depressed and book value per share is negative. Sector performance year-to-date is positive, so ALEUP.PA’s sharp drop is idiosyncratic. Investors should compare Europlasma to waste- and energy-focused small caps and monitor sector flows; weak balance sheet ratios make peer rebounds less likely without restructuring or fresh financing.

Risks, catalysts and what to watch next

Key risks: acute liquidity pressure (current ratio 0.77), negative EPS and large share count dilution (1,754,510,000 shares). Catalysts that could stabilise price include a capital raise, binding waste-treatment contracts, asset sales or clearer EBITDA improvement. Watch: company releases, trading updates, changes in shares outstanding, and any regulatory notices. Also monitor volume spikes and insider or block trades as signs of financing or strategic moves.

Final Thoughts

ALEUP.PA stock closed after hours at €0.29 on 02 Jan 2026 after an 81.23% one-day decline, reflecting a concentrated sell-off and severe stress in market confidence. Fundamentals show negative EPS of -91.38, negative free cash flow per share and a current ratio of 0.77, leaving the company more exposed than typical Industrials peers. Technical indicators point to oversold conditions but wide volatility: immediate support around €0.22 and resistance near €0.50. Meyka AI’s forecast model projects €0.23 for the month, an implied downside of -20.42% from €0.29; forecasts are model-based projections and not guarantees. Our balanced view: the Meyka grade (B+, score 73.31) highlights potential value for longer-term, risk-tolerant investors if operational improvements or financing emerge, but near-term risks remain high. Monitor corporate announcements, cash runway signals and any planned recapitalisation before considering position sizing or trading strategies.

FAQs

Why did ALEUP.PA fall so sharply on 02 Jan 2026?

The share price dropped to €0.29 on heavy volume (377,553) after a wide intraday swing; data shows acute liquidity and negative EPS which likely amplified selling. No single public news item is confirmed in the trading data; watch company releases and forums for updates.

What does the Meyka AI grade mean for ALEUP.PA?

Meyka AI rates ALEUP.PA 73.31/100 (Grade B+, BUY). The grade balances benchmark and sector comparisons, financial growth, key metrics and analyst inputs. Grades are informational, not investment advice, and not guarantees.

What are realistic near-term price targets for ALEUP.PA?

Near-term technical levels: support at €0.22 and €0.15, resistance near €0.50. Scenario targets: base €0.25, recovery test €1.50 if financing and contracts improve. Use stop limits given volatility.

How does ALEUP.PA compare to the Industrials sector?

ALEUP.PA shows weaker liquidity (current ratio 0.77) and negative cash flow metrics versus sector averages (current ratio 2.75, stronger ROE). The stock’s valuation metrics are atypical and indicate company-specific stress.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *